Items where authors include "Ren, S."
Up a levelArticle
Ren, S., Ren, S., Welton, N.J. et al. (1 more author) (2024) Advancing unanchored simulated treatment comparisons: a novel implementation and simulation study. Research Synthesis Methods. ISSN 1759-2879
Metry, A., Pandor, A. orcid.org/0000-0003-2552-5260, Ren, S. et al. (5 more authors) (2023) Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis. Health Technology Assessment, 27 (14). ISSN 1366-5278
Ren, S. orcid.org/0000-0001-9040-249X, Wang, X., Liu, P. orcid.org/0000-0002-0492-0029 et al. (1 more author) (2023) Bayesian nonparametric mixtures of Exponential Random Graph Models for ensembles of networks. Social Networks, 74. pp. 156-165. ISSN 0378-8733
Zhu, D. orcid.org/0000-0001-7784-5202, Ren, S., Mills, K. et al. (2 more authors) (2023) Rate of complete spectacle independence with a trifocal intraocular lens: a systematic literature review and meta-analysis. Ophthalmology and Therapy. pp. 1157-1171. ISSN 2193-8245
Thokala, P. orcid.org/0000-0003-4122-2366, Srivastava, T., Smith, R. et al. (5 more authors) (2023) Living health technology assessment: issues, challenges and opportunities. PharmacoEconomics, 41 (3). pp. 227-237. ISSN 1170-7690
Ren, S. orcid.org/0000-0001-9040-249X (2022) Review of Handbook of graphs and networks in people analytics: with examples in R and Python by Keith McNulty. Journal of Agricultural, Biological and Environmental Statistics. ISSN 1085-7117
Duro, E.M., Julious, S.A. orcid.org/0000-0002-9917-7636 and Ren, S. orcid.org/0000-0003-3568-7124 (2022) An investigation of the constancy of effect in Cochrane systematic reviews in context with the assumptions for noninferiority trials. BMC Medical Research Methodology, 22 (1). 204.
Mandrik, O. orcid.org/0000-0003-3755-3031, Fotheringham, J., Ren, S. orcid.org/0000-0003-3568-7124 et al. (7 more authors) (2022) The cost-effectiveness of belimumab and voclosporin for patients with Lupus Nephritis in the United States. Clinical Journal of the American Society of Nephrology, 17 (3). pp. 385-394. ISSN 1555-9041
Thokala, P. orcid.org/0000-0003-4122-2366, Stevenson, M. orcid.org/0000-0002-3099-9877, Kumar, V.M. et al. (3 more authors) (2020) Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US. Cost Effectiveness and Resource Allocation, 18. 41.
Leaviss, J. orcid.org/0000-0002-5632-6021, Davis, S. orcid.org/0000-0002-6609-4287, Ren, S. orcid.org/0000-0003-3568-7124 et al. (8 more authors) (2020) Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health Technology Assessment, 24 (46). ISSN 1366-5278
Hart, R., Burns, D., Ramaekers, B. et al. (8 more authors) (2020) R and Shiny for cost-effectiveness analyses : why and when? A hypothetical case study. PharmacoEconomics, 38. pp. 765-776. ISSN 1170-7690
Kearns, B. orcid.org/0000-0001-7730-668X, Stevens, J. orcid.org/0000-0002-9867-7209, Ren, S. orcid.org/0000-0003-3568-7124 et al. (1 more author) (2020) How uncertain is the survival extrapolation? A study of the impact of different parametric survival models on extrapolated uncertainty about hazard functions, lifetime mean survival and cost effectiveness. PharmacoEconomics, 38 (2). pp. 193-204. ISSN 1170-7690
Ren, S. orcid.org/0000-0003-3568-7124, Squires, H. orcid.org/0000-0002-2776-4014, Hock, E. orcid.org/0000-0002-8617-8875 et al. (3 more authors) (2019) Pembrolizumab for locally advanced or metastatic urothelial cancer where cisplatin is unsuitable: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics, 37 (9). pp. 1073-1080. ISSN 1170-7690
Laskier, V., Guy, H., Fisher, M. et al. (4 more authors) (2019) Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients : a systematic literature review and network meta-analysis. Journal of Medical Economics, 22 (10). pp. 1063-1072. ISSN 1369-6998
Pennington, B. orcid.org/0000-0002-1002-022X, Ren, S. orcid.org/0000-0003-3568-7124, Barton, S. et al. (2 more authors) (2019) Dinutuximab beta for treating neuroblastoma: an evidence review group and decision support unit perspective of a NICE single technology appraisal. PharmacoEconomics, 37 (8). pp. 985-993. ISSN 1170-7690
Simpson, E.L. orcid.org/0000-0001-7353-5979, Ren, S. orcid.org/0000-0003-3568-7124, Hock, E.S. orcid.org/0000-0002-8617-8875 et al. (8 more authors) (2019) Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis. International Journal of Technology Assessment in Health Care, 35 (1). pp. 36-44. ISSN 0266-4623
Bermejo, I. orcid.org/0000-0001-9105-8088, Ren, S., Simpson, E. et al. (4 more authors) (2018) Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36 (12). pp. 1427-1437. ISSN 1170-7690
Uttley, L. orcid.org/0000-0003-4603-9069, Bermejo, I., Ren, S. orcid.org/0000-0003-3568-7124 et al. (5 more authors) (2018) Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36 (9). pp. 1063-1072. ISSN 1170-7690
Ren, S. orcid.org/0000-0003-3568-7124, Bermejo, I., Simpson, E. et al. (4 more authors) (2018) Baricitinib for previously treated moderate or severe rheumatoid arthritis: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics, 36. pp. 769-778. ISSN 1170-7690
Ren, S. orcid.org/0000-0003-3568-7124, Oakley, J.E. orcid.org/0000-0002-9860-4093 and Stevens, J.W. (2018) Incorporating genuine prior information about between-study heterogeneity in random effects pairwise and network meta-analyses. Medical Decision Making, 38 (4). pp. 531-542. ISSN 0272-989X
Ren, S., Minton, J., Whyte, S. et al. (2 more authors) (2018) A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis. PharmacoEconomics, 36 (3). pp. 341-347. ISSN 1170-7690
Sadler, S., Holmes, M., Ren, S. et al. (3 more authors) (2017) Cost-effectiveness of antibiotic treatment of uncomplicated urinary tract infection in women: a comparison of four antibiotics. BJGP Open, 1 (3). bjgpopen17X101097. ISSN 2398-3795
Bojke, L., Manca, A., Asaria, M. et al. (3 more authors) (2017) How to appropriately extrapolate costs and utilities in cost-effectiveness analysis. PharmacoEconomics, 35 (8). pp. 767-776. ISSN 1170-7690
Uttley, L. orcid.org/0000-0003-4603-9069, Whyte, S., Gomersall, T. et al. (4 more authors) (2017) Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics , 35 (7). pp. 717-726. ISSN 1170-7690
Cooper, K.L. orcid.org/0000-0002-7702-8103, Martyn-St James, M., Kaltenthaler, E. et al. (6 more authors) (2017) Complementary and alternative medicine for management of premature ejaculation: a systematic review and meta-analysis. Sexual Medicine, 5 (1). e1-e18. ISSN 2050-1161
Martyn-St James, M., Cooper, K., Ren, S. et al. (6 more authors) (2017) Phosphodiesterase type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis. European Urology Focus, 3 (1). pp. 119-129. ISSN 2405-4569
Martyn-St James, M. orcid.org/0000-0002-4679-7831, Cooper, K. orcid.org/0000-0002-7702-8103, Ren, S. et al. (6 more authors) (2017) Phosphodiesterase-5 inhibitors for premature ejaculation: a systematic review and meta-analysis. European Urology Focus, 3 (1). pp. 119-129. ISSN 2405-4569
Jackson, C., Stevens, J., Ren, S. et al. (4 more authors) (2017) Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods. Medical Decision Making, 37 (4). pp. 377-390. ISSN 0272-989X
Tappenden, P. orcid.org/0000-0001-6612-2332, Ren, S., Archer, R. et al. (6 more authors) (2016) A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy. PharmacoEconomics, 34 (10). pp. 1023-1038. ISSN 1170-7690
Tappenden, P. orcid.org/0000-0001-6612-2332, Harnan, S. orcid.org/0000-0002-9318-9206, Ren, S. et al. (6 more authors) (2016) Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. ISSN 1170-7690
Archer, R., Tappenden, P., Ren, S. et al. (8 more authors) (2016) Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technoogyl Assessment, 20. 39. ISSN 1366-5278
Morrell, C.J., Sutcliffe, P., Booth, A. et al. (16 more authors) (2016) A systematic review, evidence synthesis and meta-analysis of quantitative and qualitative studies evaluating the clinical effectiveness, the cost-effectiveness, safety and acceptability of interventions to prevent postnatal depression. Health Technology Assessment , 20 (37). ISSN 1366-5278
Harnan, S. orcid.org/0000-0002-9318-9206, Ren, S., Gomersall, T. et al. (4 more authors) (2016) Association Between Transfusion Status and Overall Survival in Patients With Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis. Acta Haematologica, 136 (1). pp. 23-42. ISSN 0001-5792
Essat, M., Tappenden, P., Ren, S. et al. (5 more authors) (2015) Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690
Pandor, A., Thokala, P., Goodacre, S. et al. (7 more authors) (2015) Pre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and cost-effectiveness evaluation. Health Technology Assessment, 19 (42). 1 - 102. ISSN 1366-5278
Ren, S., Cooper, K. orcid.org/0000-0002-7702-8103, Cooper, J.A. et al. (2 more authors) (2014) PND2 – A Systematic Review and Network Meta-Analysis of Pharmacological Therapies Used for Patients with Advanced Parkinson's Disease. Value in Health, 17 (7). A390-A390. ISSN 1098-3015
Goodacre, S., Stevens, J.W., Pandor, A. et al. (11 more authors) (2014) Prehospital Noninvasive Ventilation for Acute Respiratory Failure: Systematic Review, Network Meta-analysis, and Individual Patient Data Meta-analysis. Academic Emergency Medicine, 21 (9). pp. 960-970. ISSN 1069-6563
Carroll, C. orcid.org/0000-0002-6361-6182, Hummel, S., Leaviss, J. orcid.org/0000-0002-5632-6021 et al. (4 more authors) (2014) Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. British Journal of Surgery , 101 (9). pp. 1040-1052. ISSN 0007-1323
Ren, S. and Oakley, J.E. (2014) Assurance calculations for planning clinical trials with time-to-event outcomes. Statistics in Medicine, 33 (1). 31 - 45. ISSN 0277-6715
Imanishi, T., Itoh, T., Suzuki, Y. et al. (151 more authors) (2004) Integrative Annotation of 21,037 Human Genes Validated by Full-Length cDNA Clones. PLoS Biology, 2 (6). e162. ISSN 1544-9173
Proceedings Paper
Ren, S., Minton, J., Whyte, S. et al. (2 more authors) (2017) PRM152 - How to sample ordered parameters in probabilistic sensitivity analysis. In: Value in Health. ISPOR 20th Annual European Congress, 04-08 Nov 2017, Glasgow, Scotland. Elsevier , a758-a758.